WINSOLVE-B

This brand name is authorized in Hong Kong SAR China.

Active ingredients

The drug WINSOLVE-B contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Bacitracin UNII `89Y4M234ES` - BACITRACIN ZINC
	Read more about Bacitracin
`2`	Neomycin UNII `057Y626693` - NEOMYCIN SULFATE
	Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.
	Read more about Neomycin
`3`	Polymyxin B UNII `19371312D4` - POLYMYXIN B SULFATE
	Polymixin B is bactericidal against a wide range of gram negative bacilli. It exerts a bactericidal effect by binding to acid phospholipids in the cell wall and membranes of the bacterium, thereby rendering ineffective the osmotic barrier normally provided by the cell membrane.
	Read more about Polymyxin B

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	55133

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.